Centuria Metropolitan REIT (ASX:CMA) 1H20 results & outlook
05 Feb 2020 - Centuria Metropolitan REIT (ASX:CMA) Fund Manager, Grant Nichols talks 1H20 results, portfolio metrics and guidance.
05Feb
05Feb
Centuria Industrial REIT (ASX:CIP) 1H20 results & outlook
05 Feb 2020 - Centuria Industrial REIT (ASX:CIP) Fund Manager, Jesse Curtis talks 1H20 results, portfolio metrics and trends.
03Feb
MMJ Group Holdings (ASX:MMJ) Canadian cannabis market update
03 Feb 2020 - Embark Ventures Managing Partner Michael Curtis provides an update on talks about the company's role as investment manager for MMJ Group Holdings (ASX:MMJ), the Canadian cannabis market and what’s planned for the portfolio.
03Feb
ClearVue Technologies (ASX:CPV) completes rigorous testing
03 Feb 2020 - ClearVue Technologies Limited (ASX:CPV) Executive Chairman, Victor Rosenberg, talks about certification of its solar PV Integrated Glass Unit (IGU) what the testing demonstrated and how this clears the way for sale into the US, Europe and other global territories.
31Jan
Los Cerros (ASX:LCL) – Colombian copper gold explorer
31 Jan 2020 - Los Cerros Limited (ASX:LCL) Managing Director, Jason Stirbinskis, talks about the company's gold projects in Colombia, the potential for high grade porphyry despots and plans to advance drilling at its Chuscal target.
10Jan
Novatti Group (ASX:NOV) – banking subsidiary receives major external funding, ready for licence and launch
10 Jan 2020 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, discusses funding for the Novatti's banking subsidiary, its banking licences and its core customer acquisition proposition.
09Jan
IVE Group (ASX:IGL) acquires Salmat Marketing Solutions and Reach Media New Zealand
09 Jan 2020 - IVE Group Limited (ASX:IGL) Executive Chairman, Geoff Selig, discusses the company's recent acquisition of Salmat Marketing Solutions and Reach Media New Zealand and its recent move to trading under the one IVE brand.
08Jan
SUDA Pharmaceuticals (ASX:SUD) on a new footing
08 Jan 2020 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO, Dr Michael Baker, talks about the company’s plans to develop Anagrelide, for the treatment of cancer, and to commercialise its lead product ZolpiMist worldwide.
23Dec
Cyclopharm (ASX:CYC) announces expansion of PET diagnostics business opportunities
23 Dec 2019 - Cyclopharm Limited (ASX:CYC) Managing Director and CEO, James McBrayer talks about the company's joint venture to expand Positron Emission Tomography (PET) diagnostics business opportunities for NSW and Australia.
19Dec
Renergen (ASX:RLT) discovers gas composition with 12% helium
19 Dec 2019 - Renergen Limited (ASX:RLT) CEO Stefano Marani reveals the company's discovery of a 12% helium concentration reserve at the Virginia Gas Project in South Africa.